Venkateswaran V - Search Results

1

Urinary DNA Methylation Biomarkers for Noninvasive Prediction of Aggressive Disease in Patients with Prostate Cancer on Active Surveillance.

Zhao F, Olkhov-Mitsel E, van der Kwast T, Sykes J, Zdravic D, Venkateswaran V, Zlotta AR, Loblaw A, Fleshner NE, Klotz L, Vesprini D, Bapat B. Zhao F, et al. Among authors: venkateswaran v. J Urol. 2017 Feb;197(2):335-341. doi: 10.1016/j.juro.2016.08.081. Epub 2016 Aug 18. J Urol. 2017. PMID: 27545574

2

Selenium modulation of cell proliferation and cell cycle biomarkers in human prostate carcinoma cell lines.

Venkateswaran V, Klotz LH, Fleshner NE. Venkateswaran V, et al. Cancer Res. 2002 May 1;62(9):2540-5. Cancer Res. 2002. PMID: 11980647

3

Modulation of cell proliferation and cell cycle regulators by vitamin E in human prostate carcinoma cell lines.

Venkateswaran V, Fleshner NE, Klotz LH. Venkateswaran V, et al. J Urol. 2002 Oct;168(4 Pt 1):1578-82. doi: 10.1016/S0022-5347(05)64524-7. J Urol. 2002. PMID: 12352461

4

Dietary fat and prostate cancer.

Fleshner N, Bagnell PS, Klotz L, Venkateswaran V. Fleshner N, et al. Among authors: venkateswaran v. J Urol. 2004 Feb;171(2 Pt 2):S19-24. doi: 10.1097/01.ju.0000107838.33623.19. J Urol. 2004. PMID: 14713748

5

Synergistic effect of vitamin E and selenium in human prostate cancer cell lines.

Venkateswaran V, Fleshner NE, Klotz LH. Venkateswaran V, et al. Prostate Cancer Prostatic Dis. 2004;7(1):54-6. doi: 10.1038/sj.pcan.4500707. Prostate Cancer Prostatic Dis. 2004. PMID: 14745439

6

Antioxidants block prostate cancer in lady transgenic mice.

Venkateswaran V, Fleshner NE, Sugar LM, Klotz LH. Venkateswaran V, et al. Cancer Res. 2004 Aug 15;64(16):5891-6. doi: 10.1158/0008-5472.CAN-04-0690. Cancer Res. 2004. PMID: 15313934

7

Novel antiproliferative flavonoids induce cell cycle arrest in human prostate cancer cell lines.

Haddad AQ, Venkateswaran V, Viswanathan L, Teahan SJ, Fleshner NE, Klotz LH. Haddad AQ, et al. Among authors: venkateswaran v. Prostate Cancer Prostatic Dis. 2006;9(1):68-76. doi: 10.1038/sj.pcan.4500845. Prostate Cancer Prostatic Dis. 2006. PMID: 16314891

8

Variants of the hK2 protein gene (KLK2) are associated with serum hK2 levels and predict the presence of prostate cancer at biopsy.

Nam RK, Zhang WW, Klotz LH, Trachtenberg J, Jewett MA, Sweet J, Toi A, Teahan S, Venkateswaran V, Sugar L, Loblaw A, Siminovitch K, Narod SA. Nam RK, et al. Among authors: venkateswaran v. Clin Cancer Res. 2006 Nov 1;12(21):6452-8. doi: 10.1158/1078-0432.CCR-06-1485. Clin Cancer Res. 2006. PMID: 17085659

9

Expression of TMPRSS2:ERG gene fusion in prostate cancer cells is an important prognostic factor for cancer progression.

Nam RK, Sugar L, Wang Z, Yang W, Kitching R, Klotz LH, Venkateswaran V, Narod SA, Seth A. Nam RK, et al. Among authors: venkateswaran v. Cancer Biol Ther. 2007 Jan;6(1):40-5. doi: 10.4161/cbt.6.1.3489. Cancer Biol Ther. 2007. PMID: 17172822

10

A genome-wide association screen identifies regions on chromosomes 1q25 and 7p21 as risk loci for sporadic prostate cancer.

Nam RK, Zhang WW, Loblaw DA, Klotz LH, Trachtenberg J, Jewett MA, Stanimirovic A, Davies TO, Toi A, Venkateswaran V, Sugar L, Siminovitch KA, Narod SA. Nam RK, et al. Among authors: venkateswaran v. Prostate Cancer Prostatic Dis. 2008;11(3):241-6. doi: 10.1038/sj.pcan.4501010. Epub 2007 Sep 18. Prostate Cancer Prostatic Dis. 2008. PMID: 17876339

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

90 results

Search Page